DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Twelves C, Nasim MY, Anthoney A et al.
Efficacy and safety of eribulin in combination with capecitabine in patients with metastatic breast cancer: an open-label, phase II dose-confirmation study.
San Antonio Breast Cancer Symposium; 2014 P3–13-04
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.